Zhejiang Yatai Pharmaceutical Co Ltd (002370.SZ) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · China · ISIN CNE100000MM5
Zhejiang Yatai Pharmaceutical Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 405.17 m CNY | 323.14 m CNY |
| Gross profit | 120.75 m CNY | 107.00 m CNY |
| Operating income | 28.16 m CNY | -12.24 m CNY |
| EBIT | 65.08 m CNY | 131.14 m CNY |
| Net income | 34.24 m CNY | 96.31 m CNY |
| Diluted EPS – continuing operations | 0.05 CNY | 0.13 CNY |
Full history since 2006, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Zhejiang Yatai Pharmaceutical Co Ltd
Zhejiang Yatai Pharmaceutical Co., Ltd. researches, produces, sells, and exports pharmaceutical products in China and internationally. The company offers solid dosage, cephalosporin powder injection, and freeze-dried powder injection products. It also provides antibiotic and non-antibiotic drugs. The company was founded in 1989 and is based in Shaoxing, China.
More stocks
- Binggrae (005180.KS)
- innoscripta (1INN.MU)
- Ningbo Solartron Technology Co Ltd (688299.SS)
- YungShin Global Holding Corp (3705.TW)
- Comp SA (CMP.WA)
- Hubei Xiangyuan New Material Technology Inc. (300980.SZ)
- Atria Oyj (ATRAV.HE)
- Heren Health Co Ltd (300550.SZ)
- CRESCENT BIOPHARMA, INC. (CBIO)
- Zhejiang Zhengte Co Ltd (001238.SZ)
- CHO Pharma Inc. (6586.TWO)
- First Farmers Financial Corp (FFMR)
Not investment advice. All data without warranty, price as of 11.11.2026. Details in the risk notice.